Skip to main content
logo
PT Diagnos Laboratorium Utama Tbk (IDX:DGNS)
Indonesia flag Indonesia · Delayed Price · Currency is IDR
244.00
0.00 (0.00%)
Sep 2, 2026, 11:52 AM WIB

IDX:DGNS Financials Overview

Millions IDR. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
176,486166,624163,072145,696192,886302,182
Revenue Growth
11.06%2.18%11.93%-24.46%-36.17%64.97%
Gross Profit
83,69478,28372,07459,31293,759148,555
Operating Income
5,6226,1291,924-15,15117,09981,429
Net Income
2,0442,937747.44-13,65612,66564,304
Earnings Per Share
1.552.350.60-10.9210.0051.84
EPS Growth
-292.95%---80.71%-1.60%

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
18,2019,9335,16911,94130,55351,227
Total Debt
73,05977,14670,38254,71413,2795,277
Net Cash (Debt)
-54,859-67,214-65,213-42,77317,27445,950
Net Cash Growth
-----62.41%229.33%
Net Cash Per Share
-41.80-53.77-52.17-34.2213.8237.04

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
8,67110,65827,29913,184-5,95658,875
Capital Expenditures
-4,476-8,073-43,394-38,324-34,096-67,841
Free Cash Flow
4,1952,585-16,095-25,141-40,052-8,966
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
47.42%46.98%44.20%40.71%48.61%49.16%
Operating Margin
3.19%3.68%1.18%-10.40%8.87%26.95%
Pretax Margin
2.56%3.24%0.53%-9.32%8.99%27.56%
Profit Margin
1.16%1.76%0.46%-9.37%6.57%21.28%
FCF Margin
2.38%1.55%-9.87%-17.26%-20.77%-2.97%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
157.2178.31326.11-24.0814.48
P/FCF Ratio
79.9788.99----
PS Ratio
1.901.381.502.111.583.08